Novovax’s Omicron-targeting Covid-19 vaccine obtains WHO emergency listing
Pharmaceutical Technology
NOVEMBER 28, 2023
The emergency use listing is based on non-clinical data where the vaccine demonstrated immune responses against variants in SARS-CoV-2.
Let's personalize your content